U.S. Markets closed

INSYS Therapeutics, Inc. (INSY)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
11.39-0.08 (-0.70%)
At close: 4:00PM EDT
People also watch
CARAGWPHZYNETWMJFACBFF
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue242,275330,323219,092
Cost of Revenue25,39328,85422,578
Gross Profit216,882301,469196,514
Operating Expenses
Research Development73,91356,78133,136
Selling General and Administrative131,743143,616102,388
Non Recurring3,90010,61610,616
Others---
Total Operating Expenses---
Operating Income or Loss7,32690,45660,990
Income from Continuing Operations
Total Other Income/Expenses Net1,098538153
Earnings Before Interest and Taxes8,42490,99461,143
Interest Expense---
Income Before Tax8,42490,99461,143
Income Tax Expense83432,94125,089
Minority Interest---
Net Income From Continuing Ops7,59058,05336,054
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income7,59058,05336,054
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares7,59058,05336,054